当前位置:首页 - 行情中心 - 日科化学(300214) - 财务分析 - 利润表

日科化学

(300214)

  

流通市值:59.97亿  总市值:59.97亿
流通股本:4.65亿   总股本:4.65亿

利润表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、营业总收入1,905,536,476.8912,958,078.533,741,849,463.532,826,848,472.82
  营业收入1,905,536,476.8912,958,078.533,741,849,463.532,826,848,472.82
二、营业总成本1,881,139,906.56916,887,779.23,752,618,132.452,859,520,083.82
  营业成本1,756,576,444.69846,972,418.313,484,730,451.842,695,190,262.31
  税金及附加12,346,431.086,076,755.222,678,751.2518,809,805.78
  销售费用17,170,517.778,996,348.9337,982,908.1626,572,838.4
  管理费用46,331,364.2929,057,855.9107,770,367.5860,614,841.47
  研发费用16,086,823.249,093,005.6247,561,712.3327,742,565.64
  财务费用32,628,325.4916,691,395.2451,893,941.2930,589,770.22
  其中:利息费用23,827,546.5811,578,846.0444,633,925.4332,862,077.44
  其中:利息收入1,135,729.97952,167.222,548,755.971,183,248.09
三、其他经营收益
  加:公允价值变动收益000-
  加:投资收益2,954,668.732,103,607.1941,747.211,850,016.24
  净敞口套期收益000-
  资产处置收益14,380,403.473,121,167.353,860,589.064,276,463.95
  资产减值损失(新)4,135,624.550-9,097,990.2217,604,733.28
  信用减值损失(新)-3,765,299.91,638,012.32-1,045,266.31-2,124,988.45
  其他收益4,560,877.092,627,667.112,807,076.827,567,707.11
四、营业利润46,662,844.185,560,753.2-3,302,512.36-3,497,678.87
  加:营业外收入159,510.3539,765.18515,154.545,593.12
  减:营业外支出1,404,671.68397,377.651,373,507.161,614,767.83
五、利润总额45,417,682.855,203,140.73-4,160,865.02-5,066,853.58
  减:所得税费用10,442,614.161,122,892.0530,905,358.13-5,578,181.64
六、净利润34,975,068.694,080,248.68-35,066,223.15511,328.06
(一)按经营持续性分类
  持续经营净利润34,975,068.694,080,248.68-35,066,223.15511,328.06
(二)按所有权归属分类
  归属于母公司股东的净利润30,272,680.442,077,680.19-29,707,578.344,016,187.89
  少数股东损益4,702,388.252,002,568.49-5,358,644.81-3,504,859.83
  扣除非经常损益后的净利润25,256,519.62723,806.31-38,155,856.48599,032.92
七、每股收益
  (一)基本每股收益0.070-0.060.01
  (二)稀释每股收益0.070-0.060.01
九、综合收益总额34,975,068.694,080,248.68-35,066,223.15511,328.06
  归属于母公司股东的综合收益总额30,272,680.442,077,680.19-29,707,578.344,016,187.89
  归属于少数股东的综合收益总额4,702,388.252,002,568.49-5,358,644.81-3,504,859.83
公告日期2026-08-212026-04-272026-04-272025-10-23
审计意见(境内)标准无保留意见
TOP↑